nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus
|
Tiwari, Mugdha |
|
2009 |
27 |
18 |
p. 2513-2522 10 p. |
artikel |
2 |
Booster vaccination of toddlers with reduced antigen content diphtheria–tetanus–acellular pertussis vaccine
|
Nolan, Terry |
|
2009 |
27 |
18 |
p. 2410-2413 4 p. |
artikel |
3 |
Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes
|
Santiago, Araceli E. |
|
2009 |
27 |
18 |
p. 2426-2436 11 p. |
artikel |
4 |
DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial
|
Jones, Suzanne |
|
2009 |
27 |
18 |
p. 2506-2512 7 p. |
artikel |
5 |
Editorial Board
|
|
|
2009 |
27 |
18 |
p. CO2- 1 p. |
artikel |
6 |
Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant
|
Cardona, P.J. |
|
2009 |
27 |
18 |
p. 2499-2505 7 p. |
artikel |
7 |
Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults
|
McElhaney, Janet E. |
|
2009 |
27 |
18 |
p. 2418-2425 8 p. |
artikel |
8 |
Immunogenicity of recombinant protective antigen and efficacy against intranasal challenge with Bordetella bronchiseptica
|
Zhao, Zhanqin |
|
2009 |
27 |
18 |
p. 2523-2528 6 p. |
artikel |
9 |
Induction of partial protection against infection with Toxoplasma gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite antigens
|
Rosenberg, Carina |
|
2009 |
27 |
18 |
p. 2489-2498 10 p. |
artikel |
10 |
Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible
|
Gelinck, L.B.S. |
|
2009 |
27 |
18 |
p. 2469-2474 6 p. |
artikel |
11 |
Mycoplasma pneumoniae vaccine protective efficacy and adverse reactions—Systematic review and meta-analysis
|
Linchevski, Inbal |
|
2009 |
27 |
18 |
p. 2437-2446 10 p. |
artikel |
12 |
On the use of hemagglutination-inhibition for influenza surveillance: Surveillance data are predictive of influenza vaccine effectiveness
|
Ndifon, Wilfred |
|
2009 |
27 |
18 |
p. 2447-2452 6 p. |
artikel |
13 |
Predictors of interest in HPV vaccination: A study of British adolescents
|
Marlow, Laura A.V. |
|
2009 |
27 |
18 |
p. 2483-2488 6 p. |
artikel |
14 |
Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy
|
Roukens, Anna H. |
|
2009 |
27 |
18 |
p. 2408-2409 2 p. |
artikel |
15 |
Report of the Fifth AREB Meeting
|
Dodet, B. |
|
2009 |
27 |
18 |
p. 2403-2407 5 p. |
artikel |
16 |
Single dose intranasal immunization with ISCOMATRIX™ vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract
|
Sanders, Megan T. |
|
2009 |
27 |
18 |
p. 2475-2482 8 p. |
artikel |
17 |
Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity
|
Giezeman, K.M. |
|
2009 |
27 |
18 |
p. 2414-2417 4 p. |
artikel |
18 |
Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen
|
Mealey, Robert H. |
|
2009 |
27 |
18 |
p. 2453-2468 16 p. |
artikel |